Related references
Note: Only part of the references are listed.The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer
Xiaochen Liu et al.
ONCOGENE (2020)
Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer
Teng Ma et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer
Yanjun Li et al.
ONCOGENESIS (2020)
Wogonin Induces Apoptosis and Reverses Sunitinib Resistance of Renal Cell Carcinoma CellsviaInhibiting CDK4-RB Pathway
Yong Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents
Kyung Chan Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2020)
CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c
Meng Jiao et al.
PROSTATE (2019)
CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression
Mingfeng Zhao et al.
PROSTATE (2019)
Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer
Nadia Boromand et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2
M. Qi et al.
ONCOGENE (2018)
Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway
Wei Gao et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway
Chunxiu Dai et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
miR-146a targets c-met and abolishes colorectal cancer liver metastasis
Anne-Marie Bleau et al.
CANCER LETTERS (2018)
c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival
Su Jin Lee et al.
CLINICAL COLORECTAL CANCER (2018)
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Yazhuo Zhang et al.
MOLECULAR CANCER (2018)
C-Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives
Afsane Bahrami et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Dysregulation of the miR-194-CUL4B negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma
Jun Mi et al.
MOLECULAR ONCOLOGY (2017)
The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review
Shouzhen Chen et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Clinicopathological and prognostic significance of c-Met overexpression in breast cancer
Xixi Zhao et al.
ONCOTARGET (2017)
The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas
Aleksandra Paliga et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target
Tamer Refaat et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Toni K. Choueiri et al.
LANCET ONCOLOGY (2016)
Knockdown of CUL4B Suppresses the Proliferation and Invasion in Non-Small Cell Lung Cancer Cells
Xuguang Wang et al.
ONCOLOGY RESEARCH (2016)
CUL4B activates Wnt/beta-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists
Jupeng Yuan et al.
JOURNAL OF PATHOLOGY (2015)
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3 A in DNA methylation-based epigenetic silencing
Y. Yang et al.
ONCOGENE (2015)
Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform
Li Ying et al.
PLOS ONE (2015)
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma
G. T. Gibney et al.
ANNALS OF ONCOLOGY (2013)
A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma
M. Yashiro et al.
BRITISH JOURNAL OF CANCER (2013)
Targeting the Hepatocyte Growth Factor/c-Met Signaling Pathway in Renal Cell Carcinoma
Lauren C. Harshman et al.
CANCER JOURNAL (2013)
Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis
Tao Jiang et al.
MEDICAL ONCOLOGY (2013)
CRL4B Catalyzes H2AK119 Monoubiquitination and Coordinates with PRC2 to Promote Tumorigenesis
Huili Hu et al.
CANCER CELL (2012)
Pathogenic role of the CRL4 ubiquitin ligase in human disease
Jennifer Lee et al.
FRONTIERS IN ONCOLOGY (2012)
Lymph Node Dissection at the Time of Radical Nephrectomy for High-Risk Clear Cell Renal Cell Carcinoma: Indications and Recommendations for Surgical Templates
Paul L. Crispen et al.
EUROPEAN UROLOGY (2011)
The Epidemiology of Renal Cell Carcinoma
Borje Ljungberg et al.
EUROPEAN UROLOGY (2011)
Deletion of the CUL4B Gene in a Boy With Mental Retardation, Minor Facial Anomalies, Short Stature, Hypogonadism, and Ataxia
Bertrand Isidor et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Characterization of Nuclear Localization Signal in the N Terminus of CUL4B and Its Essential Role in Cyclin E Degradation and Cell Cycle Progression
Yongxin Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
CRL4s: the CUL4-RING E3 ubiquitin ligases
Sarah Jackson et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and wnt activity in colon cancer
Jurriaan B. Tuynman et al.
CANCER RESEARCH (2008)
Cullin-RING ubiquitin ligases: global regulation and activation cycles
Dimple R Bosu et al.
Cell Division (2008)
Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation
Yongxin Zou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway
Qiao Meng et al.
CELLULAR SIGNALLING (2006)
Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma
Yasuyoshi Miyata et al.
CLINICAL CANCER RESEARCH (2006)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
c-Cbl is involved in met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination
TEI Taher et al.
JOURNAL OF IMMUNOLOGY (2002)
Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein
P Peschard et al.
MOLECULAR CELL (2001)
Share Paper
